Canada: A recent observational cohort study from Canada revealed that older diabetic patients taking GLP-1 receptor ...

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...

GLP-1 RAs may significantly increase the risk of neovascular age-related macular degeneration in older adults with diabetes.

A new study found a link between GLP-1s and a higher risk of neovascular age-related macular degeneration, an eye disease ...

Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s ...

HealthDay News — For patients with diabetes, exposure to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with an increased risk for incident neovascular age-related macular ...

Intravitreal anti-VEGF agents are linked to a slight increase in the risk for stroke in patients with age-related macular ...

Older diabetic patients on two GLP-1 drugs showed an increased risk of neovascular age-related macular degeneration in an observational cohort study. The absolute risk was small, however, reaching ...

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing neovascular age-related macular degeneration (nAMD) in older patients with ...

More than twofold increased risk seen for nAMD development in unadjusted and adjusted models. HealthDay News — For patients with diabetes, exposure to glucagon-like peptide-1 receptor agonists ...

GLP-1 RA use was linked to a 2.21-fold risk of developing neovascular age-related macular degeneration// (nAMD) * Only 0.2% ...

With 35+ lectures, a NASA keynote, and a river cruise through historic Heidelberg, this year’s symposium blends science and ...